Can Beta-D-Glucan testing as part of the diagnostic pathway for invasive fungal infection reduce anti-fungal treatment costs?
David O HamiltonTosin LambeAlexander HowardPatricia CrosseyJennifer HughesRui DuarteIngeborg D WeltersPublished in: Medical mycology (2022)
Invasive fungal infection increases the risk of death in very sick people. So, treatment is started before test results are known. Beta-D-Glucan (BDG) test is faster than standard blood culture tests. We estimate that using BDG tests in how patients are diagnosed could save about £1643 per patient.